Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD)

Francesco Deodato, Maria Antonietta Gambacorta, Giovanni Scambia, Vincenzo Valentini, Maria Gabriella Ferrandina, Gabriella Macchia, Barbara Alicja Jereczek-Fossa, Roberta Lazzari, Annamaria Cerrotta, Edy Ippolito, Cynthia Aristei

Research output: Contribution to journal › Article

Fingerprint

Dive into the research topics of 'Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD)'. Together they form a unique fingerprint.

Medicine & Life Sciences